ImmunologybioRxivPreprint
Impaired tumor death receptor signaling drives resistance to CAR T cell therapy
N. Singh, O. Shestova, P. Ravikumar…·M. Ruella
This study identifies impaired death receptor signaling as a driver of resistance to CAR T cell therapy in B-cell leukemia by showing its role in tumor survival and T cell dysfunction.